PACS Group, Inc. (PACS)
- Sector
- Health Care
- Last price
- $44.38
- As of
Kresmion compiles this page from PACS's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
PACS Group, Inc. (PACS): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-21.
See the full PACS dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PACS on one page. Preview it with sample data, then open it live with a free account.
Preview the PACS dossierActive signals for PACS
- highCONSENSUS_SELL
5 tracked funds reduced PACS this 2026Q2, institutional consensus
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 15.2%, EPS $0.63 vs $0.5467 estimate
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +383% to PACS (2026Q2)
- highCONSENSUS_SELL
3 tracked funds reduced PACS this 2026Q2, institutional consensus
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 81% of PACS (2026Q2)
FREE, NO ACCOUNT
Every signal on PACS, as it fires
You are seeing 5 of 16 signals recorded on PACS since 2026-05-31.
The five above landed across 3 days. The other 11 were recorded on 3 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in PACS (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LPCUSIP 69380Q107 · 2026Q2 | $7.1M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 69380Q107 · 2026Q2 | $6.2M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 69380Q107 · 2026Q2 | $3.1M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 69380Q107 · 2026Q2 | $337K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, PACS
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
PACS against its peers
PACS's operating margin of 5.9% ranks in the 37th percentile of 22 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | PACS | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 5.3B USD | 1.5B USD | 83 | 25 |
| Gross margin | n/a | 60.1% | n/a | 18 |
| Operating margin | 5.9% | 8.2% | 37 | 22 |
| Net margin | 3.6% | 3.7% | 48 | 25 |
| Return on equity | 20.2% | 8.1% | 75 | 25 |
| P / E | 36.4x | 39.2x | 44 | 16 |
| 1 year | 257.9% | 14.8% | 98 | 23 |
Peers (25): LNTH, CHE, HIMS, HNGE, RDNT, DOCS, HAE, TFX, MMSI, WAY, MASI, GKOS, ENSG, OPCH, MOH, ITGR, LIVN, CRVL, EHC, PEN, BTSG, NVST, IRTC, ATRC, ACHC. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (PACS: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow PACS on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to PACS for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.